KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gilead Sciences (GILD) Return on Sales (2016 - 2025)

Gilead Sciences (GILD) has disclosed Return on Sales for 17 consecutive years, with 0.32% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Sales rose 8.0% year-over-year to 0.32%, compared with a TTM value of 0.3% through Dec 2025, up 28.0%, and an annual FY2025 reading of 0.29%, up 27.0% over the prior year.
  • Return on Sales was 0.32% for Q4 2025 at Gilead Sciences, down from 0.39% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.39% in Q3 2025 and bottomed at 0.62% in Q1 2024.
  • Average Return on Sales over 5 years is 0.18%, with a median of 0.23% recorded in 2022.
  • The sharpest move saw Return on Sales skyrocketed 89bps in 2021, then plummeted -78bps in 2024.
  • Year by year, Return on Sales stood at 0.05% in 2021, then soared by 326bps to 0.22% in 2022, then dropped by -10bps to 0.2% in 2023, then increased by 18bps to 0.24% in 2024, then surged by 35bps to 0.32% in 2025.
  • Business Quant data shows Return on Sales for GILD at 0.32% in Q4 2025, 0.39% in Q3 2025, and 0.28% in Q2 2025.